Evidence map›Paper›PMID 41888871›Full record

ReviewCancer imaging : the official publication of the International Cancer Imaging Society2026

RADS classification systems for bone tumors: current status and where do we go from here?

Vu Pham Thao Vy, Shivani Ahlawat, Hillary W Garner, Jim S Wu

Abstract readReview
In one paragraph

Review in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vu Pham Thao VyCollege of Medicine, Taipei Medical Universtiy, Taipei, Taiwan.
Shivani AhlawatRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hillary W GarnerDepartment of Radiology, Mayo Clinic, Jacksonville, FL, USA.
Jim S WuDepartment of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA. jiwu@bwh.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The assessment and management of bone tumors can be challenging as there are numerous neoplastic and non-neoplastic lesions. It can be difficult to understand which lesions can be ignored and which lesions require treatment. To standardize the reporting and management of bone tumors, four bone-lesion related reporting and data systems (RADS) have been published since 2021. The Bone Tumor Imaging Reporting and Data System (BTI-RADS), Oncologic Tumor Reporting and Data System (OT-RADS), Society of Skeletal Radiology Bone Reporting and Data System (SSR Bone-RADS), and American College of Radiology Bone Reporting and Data System (ACR Bone-RADS) are based in part on Breast Imaging Reporting & Data System (BI-RADS). These bone-lesion related RADS aim to improve communication, simplify management, and improve diagnostic consistency by linking imaging features to specific risks and evidence-based action recommendations. Although these systems show high sensitivity for determination of malignancy and moderate consistency for intra-observer readings, their coexistence leads to fragmentation and a lack of a unifying system. This review will discuss the main features of these 4 RADS systems and discuss future directions.

Indexed as

Bone NeoplasmsRadiology Information SystemsHumansBone tumorsMusculoskeletal imagingReporting and data systems (RADS)

Identifiers

PMID41888871
PMCPMC13141412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.